Showing 351-353 of 353 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Genetic variation in RPS26 modulates beta-cell vitality and immunogenicity in type 1 diabetes | Yale University | David Alagpulinsa | Cures | 01-April-2026 to 31-March-2027 | $199.959,68 |
| Harnessing hematopoietic function in acute lymphoblastic leukemia to treat type 1 diabetes | Yale University | David Alagpulinsa | Cures | 01-March-2025 to 28-February-2030 | $991.634,17 |
| Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta-cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D | Yale University | Alfonso Galderisi | Cures | 01-February-2023 to 30-September-2026 | $747.380,88 |